Fig. 2 | Scientific Reports

Fig. 2

From: Exploring the active ingredients of Banzhilian and its mechanism of action on diabetic Gastric cancer based on network pharmacology

Fig. 2The alternative text for this image may have been generated using AI.

Prediction of Banzhilian’s components and targets in anti-GC-diabetes, along with GO and KEGG analysis. (A) Diabetes-related genes. (B) GC-related genes. (C) Identification of intersection targets between Banzhilian and GC-diabetes. (D) Interaction between Banzhilian’s active components and GC-diabetes pathogenic genes. (E,F) Key targets were identified using the CytoNCA plugin. (G) GO analysis. (H) KEGG enrichment analysis.

Back to article page